<scp>CD</scp>70 and <scp>PD</scp>‐L1 in anaplastic thyroid cancer – promising targets for immunotherapy

Abstract

These data suggest that targeted immunotherapy for CD70/CD27 and PD-L1/PD-1 might be promising in anaplastic thyroid cancer. However, as a low amount of tumour-infiltrating lymphocytes was observed in most lesions, combined therapy with agents enhancing the invasion of lymphocytes in the tumour region needs to be considered.